| Basics |
Atai Life Sciences N.V.
ATA Inc is a computer-based testing service provider. The company offers testing systems such as test development, test delivery, and data management. It also provides test-based training, education programs, and test preparation courses to individuals.
|
| IPO Date: |
June 18, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$293.7M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.15 | 3.80%
|
| Avg Daily Range (30 D): |
$0.05 | 4.01%
|
| Avg Daily Range (90 D): |
$0.08 | 4.76%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.04M |
| Avg Daily Volume (30 D): |
1.49M |
| Avg Daily Volume (90 D): |
2.3M |
| Trade Size |
| Avg Trade Size (Sh.): |
203 |
| Avg Trade Size (Sh.) (30 D): |
313 |
| Avg Trade Size (Sh.) (90 D): |
319 |
| Institutional Trades |
| Total Inst.Trades: |
102 |
| Avg Inst. Trade: |
$1.55M |
| Avg Inst. Trade (30 D): |
$1.15M |
| Avg Inst. Trade (90 D): |
$.95M |
| Avg Inst. Trade Volume: |
.33M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.07M |
| Avg Closing Trade (30 D): |
$.76M |
| Avg Closing Trade (90 D): |
$.91M |
| Avg Closing Volume: |
666.56K |
|
|
|
|
| Financials |
| |
TTM |
Q4 2024 |
FY 2024 |
|
Basic EPS
|
$-.93
|
$-.24
|
$-.93
|
|
Diluted EPS
|
$-.93
|
$-.24
|
$-.93
|
|
Revenue
|
$ .31M
|
$ -.01M
|
$ .31M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -150.05M
|
$ -38.99M
|
$ -150.05M
|
|
Operating Income / Loss
|
$ -102.69M
|
$ -30.27M
|
$ -102.69M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -17.89M
|
$ -17.58M
|
$ -17.89M
|
|
PE Ratio
|
|
|
|
|
